🧬Tidera Health

Tidera provides educational trial discovery tools and does not provide medical advice or determine eligibility. Always discuss options with your care team.

Research Explained6 min read

Open-Label Extension Studies: Getting Long-Term Access to Investigational Drugs

By Tidera Health Editorial Team·

If a trial ends and you've benefited from the drug, an open-label extension may let you keep taking it. Here's how OLE studies work.

About this article: Educational and informational only. Does not constitute medical advice or eligibility guidance. Always discuss clinical trial options with your care team. Verify current trial status at ClinicalTrials.gov.

What You Need to Know

After a randomized trial ends, open-label extension studies let participants continue receiving the investigational drug. This guide explains what OLEs are and how to access them.

Find recruiting trials for your condition

Search ClinicalTrials.gov in real time — matched to your profile, explained in plain English. Free, no account required.

Start Free Search →

How Tidera Health Can Help

Tidera Health searches ClinicalTrials.gov in real time and uses AI to explain which trials may be relevant to your condition, age, location, and treatment history. It's free, requires no account, and stores no health data.

Enter your condition and location to see currently recruiting trials matched to your profile — with plain-English eligibility explanations and questions to ask the research coordinator.

Topics

open label extensionOLE studylong-term trial accesscontinued access trial

Find recruiting trials for your condition

Enter your condition, age, and location. We search ClinicalTrials.gov in real time and explain each trial in plain English. Free, no account required.